CIK: 0001012622 · Show all filings
Period: Q3 2016 (← Previous) (Next →)
Filing Date: Nov 14, 2016
Total Value ($000): $648,928 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ACCELERATE DIAGNOSTICS INC | 5,092,727 | $138,828 | 21.4% | $24998.12 | — | COM | 004304200 |
| — | TESARO INC | 1,154,322 | $115,709 | 17.8% | $13840.04 | — | COM | 881569107 |
| — | MAZOR ROBOTICS LTD | 2,766,517 | $71,570 | 11.0% | $11234.47 | — | SPONSORED ADS | 57886P103 |
| — | NXSTAGE MEDICAL INC | 2,671,936 | $66,772 | 10.3% | $13115.35 | — | COM | 67072V103 |
| — | QUIDEL CORP | 2,533,554 | $55,966 | 8.6% | $25530.00 | — | COM | 74838J101 |
| OPK | OPKO HEALTH INC | 4,546,820 | $48,151 | 7.4% | $7.38 | +34.9% | COM | 68375N103 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 4,998,566 | $44,787 | 6.9% | $5.65 | +48.0% | COM | 69404D108 |
| — | BIOLASE INC | 14,228,625 | $22,607 | 3.5% | $1127.30 | — | COM | 090911108 |
| — | AMARIN CORP PLC | 6,094,272 | $19,441 | 3.0% | $884.78 | — | SPONS ADR NEW | 023111206 |
| — | INTREXON CORP | 662,642 | $18,567 | 2.9% | $5288.41 | — | COM | 46122T102 |
| ARAY | ACCURAY INC | 2,482,718 | $15,815 | 2.4% | $5.71 | -4.4% | COM | 004397105 |
| — | AGENUS INC | 1,984,820 | $14,251 | 2.2% | $986.80 | — | COM | 00847G101 |
| — | VERMILLION INC | 8,624,225 | $11,211 | 1.7% | $1646.88 | — | COM NEW | 92407M206 |
| — | CONTRAFECT CORP | 1,182,032 | $2,931 | 0.5% | $5.25 | — | COM | 212326102 |
| BIIB | BIOGEN INC | 6,723 | $2,105 | 0.3% | $213.68 | +38.6% | COM | 09062X103 |
| — | SECOND SIGHT MED PRODS INC | 50,804 | $179 | 0.0% | $10.26 | — | COM | 81362J100 |
| — | ZIOPHARM ONCOLOGY INC | 6,661 | $38 | 0.0% | $12.00 | — | COM | 98973P101 |